| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormalities in the circadian rhythm of parathyroid hormone and serum bone markers in adults with growth hormone deficiency
|
Hopkins, M.T.
|
|
1999
|
9 |
S1 |
p. 162-
1 p.
|
artikel
|
| 2 |
Administration of growth hormone to catabolic patients
|
Hinds, C.J.
|
|
1999
|
9 |
S1 |
p. 71-75
5 p.
|
artikel
|
| 3 |
Adult growth hormone deficiencysyndrome: A personal approach to diagnosis, treatment and monitoring
|
Cook, D.M.
|
|
1999
|
9 |
S1 |
p. 129-133
5 p.
|
artikel
|
| 4 |
A low growth hormone (GH) dose given to youngadults with childhood-onset GH deficiency increases kidney length
|
Link, K.
|
|
1999
|
9 |
S1 |
p. 148-
1 p.
|
artikel
|
| 5 |
A low growth hormone (GH) dose given to youngadults with childhood-onset GH deficiency increases left ventricular mass
|
Link, K.
|
|
1999
|
9 |
S1 |
p. 146-
1 p.
|
artikel
|
| 6 |
Applications of new geneticapproaches to growth hormone-releasing hormone receptor defects
|
Phillips, J.A.
|
|
1999
|
9 |
S1 |
p. 45-49
5 p.
|
artikel
|
| 7 |
A study of adults with Prader-Willi syndrome
|
Höybye, C.
|
|
1999
|
9 |
S1 |
p. 163-
1 p.
|
artikel
|
| 8 |
Body composition and serum leptin levels inpatients with hypopituitarism
|
Paramo, C.
|
|
1999
|
9 |
S1 |
p. 153-
1 p.
|
artikel
|
| 9 |
Defects of the growth hormonereceptor and their clinical implications
|
Savage, M.O.
|
|
1999
|
9 |
S1 |
p. 57-61
5 p.
|
artikel
|
| 10 |
Dehydroepiandrosterone sulphate levels inpatients with hypopituitarism and severe growth hormone (GH) deficiency: Comparison with insulin-like growth factor I levels before and during GH replacement
|
Aimaretti, G.
|
|
1999
|
9 |
S1 |
p. 141-
1 p.
|
artikel
|
| 11 |
Detection of growth hormone gene defects bydideoxy fingerprinting
|
Miyata, I.
|
|
1999
|
9 |
S1 |
p. 159-
1 p.
|
artikel
|
| 12 |
Discontinuation of growth hormone treatmentin adolescent patients: Effects on metabolic parameters, quality of life and psychological well-being
|
Johannsson, G.
|
|
1999
|
9 |
S1 |
p. 142-
1 p.
|
artikel
|
| 13 |
Echocardiographic evaluation of cardiac function in transgenic mice over-expressing the bovine growth hormone gene
|
Bohlooly-Y, M.
|
|
1999
|
9 |
S1 |
p. 156-
1 p.
|
artikel
|
| 14 |
Effect of growth hormone (GH) replacementtherapy on the body composition of adults with GH deficiency
|
Guisti, V.
|
|
1999
|
9 |
S1 |
p. 149-
1 p.
|
artikel
|
| 15 |
Effect of growth hormone (GH) treatment on biochemical bone markers and bone mineral density in GH-deficient adults
|
Bayraktar, F.
|
|
1999
|
9 |
S1 |
p. 161-
1 p.
|
artikel
|
| 16 |
Effect of growth hormone treatment in an experimental model of focal glomerular sclerosis
|
Fujimoto, M.
|
|
1999
|
9 |
S1 |
p. 157-
1 p.
|
artikel
|
| 17 |
Effect of leptin on basal and follicle-stimulating hormone stimulated steroidogenesis in human granulosa cells
|
Greisen, S.
|
|
1999
|
9 |
S1 |
p. 152-
1 p.
|
artikel
|
| 18 |
Effect of 30 months of growth hormone (GH) replacement therapy on bone metabolism in adults with GH deficiency
|
Kaldrymidis, P.H.
|
|
1999
|
9 |
S1 |
p. 161-
1 p.
|
artikel
|
| 19 |
Effect of the liver proliferator cyproterone acetate on liver growth in interleukin-6-deficient mice
|
Wallenius, V.
|
|
1999
|
9 |
S1 |
p. 155-
1 p.
|
artikel
|
| 20 |
Effects of growth hormone (GH) replacement therapy on quality of life in adults with GH deficiency
|
Heberling, H.A.
|
|
1999
|
9 |
S1 |
p. 143-
1 p.
|
artikel
|
| 21 |
Effects of growth hormone (GH) treatment onvery-low-density lipoprotein apolipoprotein 13100 turnover in GH deficient adults
|
Chrisoulidou, A.
|
|
1999
|
9 |
S1 |
p. 145-
1 p.
|
artikel
|
| 22 |
Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans
|
Rudling, M.
|
|
1999
|
9 |
S1 |
p. 1-7
7 p.
|
artikel
|
| 23 |
Endocrine changes in criticallyill patients
|
Van den Berghe, G.
|
|
1999
|
9 |
S1 |
p. 77-81
5 p.
|
artikel
|
| 24 |
Foreword
|
Brummer, Robert-Jan
|
|
1999
|
9 |
S1 |
p. iii-
1 p.
|
artikel
|
| 25 |
Growth hormone and ageing
|
van der Lely, A.J.
|
|
1999
|
9 |
S1 |
p. 117-119
3 p.
|
artikel
|
| 26 |
Growth hormone conserves nitrogen andaccelerates lipolysis during dietary restriction in obese women
|
Norrelund, H.
|
|
1999
|
9 |
S1 |
p. 151-
1 p.
|
artikel
|
| 27 |
Growth hormone deficiency andatherosclerosis — is there a link?
|
McGrath, S.
|
|
1999
|
9 |
S1 |
p. 9-13
5 p.
|
artikel
|
| 28 |
Growth hormone (GH) andatherosclerosis: changes in morphology and function of major arteries during GH treatment
|
Pfeifer, M.
|
|
1999
|
9 |
S1 |
p. 25-30
6 p.
|
artikel
|
| 29 |
Growth hormone (GH) secretagoguesand neuroendocrine regulation of GH secretion
|
Dickson, S.L.
|
|
1999
|
9 |
S1 |
p. 89-91
3 p.
|
artikel
|
| 30 |
Growth hormone (GH) secretion in GH-deficientadults and obese patients: Effect of the administration of acipimox on GH secretion mediated by GH-releasing hormone
|
Cordido, F.
|
|
1999
|
9 |
S1 |
p. 137-
1 p.
|
artikel
|
| 31 |
Growth hormone receptor associated JAK proteins in the liver: Differences between rats and humans
|
Hellgren, G.
|
|
1999
|
9 |
S1 |
p. 154-
1 p.
|
artikel
|
| 32 |
Growth hormone secretagogues:A pill for growth?
|
Clark, R.G.
|
|
1999
|
9 |
S1 |
p. 85-88
4 p.
|
artikel
|
| 33 |
Growth hormone secretagogues astherapeutic agents
|
Svensson, J.
|
|
1999
|
9 |
S1 |
p. 107-109
3 p.
|
artikel
|
| 34 |
Growth hormone secretion in patients withacromegaly: Effect of acute administration of acipimox
|
Cordido, F.
|
|
1999
|
9 |
S1 |
p. 138-
1 p.
|
artikel
|
| 35 |
Growth hormone stimulates expression and DNA-binding activity of CCAAT/enhancer binding protein-α in primary cultures of rat hepatocytes
|
Strand, P.
|
|
1999
|
9 |
S1 |
p. 154-
1 p.
|
artikel
|
| 36 |
Growth hormone therapy with dietary restrictiondecreases insulin resistance by reducing visceral fat and increasing muscle mass in obese patients with type 2 diabetes mellitus
|
Nam, S.Y.
|
|
1999
|
9 |
S1 |
p. 150-
1 p.
|
artikel
|
| 37 |
Growth hormone therapy with Genotropin MiniQuick® offers improved convenience
|
Sjöblom, K.
|
|
1999
|
9 |
S1 |
p. 143-
1 p.
|
artikel
|
| 38 |
Growth hormone treatment in critical illness — a critical appraisal
|
Isaksson, O.G.P.
|
|
1999
|
9 |
S1 |
p. 83-84
2 p.
|
artikel
|
| 39 |
High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: Preliminary results
|
Erfurth, E.M.
|
|
1999
|
9 |
S1 |
p. 21-24
4 p.
|
artikel
|
| 40 |
Hormone abuse in sport
|
Russell-Jones, D.L.
|
|
1999
|
9 |
S1 |
p. 63-65
3 p.
|
artikel
|
| 41 |
Human adipose tissue expresses angiotensinogen and the enzymes required for its conversion to angiotensin II
|
Carlsson, L.
|
|
1999
|
9 |
S1 |
p. 156-
1 p.
|
artikel
|
| 42 |
Identification of a peroxisomal targeting signal inthe high-density lipoprotein receptor, scavenger receptor class B type I
|
Johnson, M.S.C.
|
|
1999
|
9 |
S1 |
p. 159-
1 p.
|
artikel
|
| 43 |
Increased leptin levels in women withhypopituitarism and childhood-onset growth hormone deficiency
|
Krzyzanowska, B.
|
|
1999
|
9 |
S1 |
p. 152-
1 p.
|
artikel
|
| 44 |
Influence of glucocorticoid replacementtherapy on body composition in growth hormone deficient adults: Possible consequences for insulin sensitivity
|
Beentjes, J.A.M.
|
|
1999
|
9 |
S1 |
p. 150-
1 p.
|
artikel
|
| 45 |
Insulin-like growth factor (IGF-I), IGF-bindingprotein and the acid-labile subunit responses to short-term growth hormone administration in paediatric patients with liver disease
|
Jones, J.S.
|
|
1999
|
9 |
S1 |
p. 162-
1 p.
|
artikel
|
| 46 |
Insulin-like growth factor signalling pathways in rat hepatic stellate cells: Effects on DNA synthesis and hepatocyte growth factor production
|
Skrtic, S.
|
|
1999
|
9 |
S1 |
p. 155-
1 p.
|
artikel
|
| 47 |
Insulin sensitivity and urinary C-peptide excretionin adults with growth hormone (GH) deficiency: Effects of GH replacement therapy
|
Sinay, I.
|
|
1999
|
9 |
S1 |
p. 144-145
2 p.
|
artikel
|
| 48 |
In vivo and in vitro expression of somatostatinreceptor subtypes in human pituitary adenomas and correlation to expression of gonadotropin-releasing hormone receptor mRNA
|
Nielsen, S.
|
|
1999
|
9 |
S1 |
p. 158-
1 p.
|
artikel
|
| 49 |
Molecular and cell biology ofthe growth hormone-releasing hormone receptor
|
Gaylinn, B.D.
|
|
1999
|
9 |
S1 |
p. 37-44
8 p.
|
artikel
|
| 50 |
Mortality and hypopituitarism
|
Stewart, P.M.
|
|
1999
|
9 |
S1 |
p. 15-19
5 p.
|
artikel
|
| 51 |
Neuroendocrinology of the humangrowth hormone-insulin-like growth factor I axis during ageing
|
Arvat, E.
|
|
1999
|
9 |
S1 |
p. 111-115
5 p.
|
artikel
|
| 52 |
Nitric oxide and arginine
|
Vallance, P.
|
|
1999
|
9 |
S1 |
p. 31-35
5 p.
|
artikel
|
| 53 |
Observational study in adults with hypopituitarism and untreated growth hormone deficiency: Health and socioeconomic impact
|
Sanmarti, A.
|
|
1999
|
9 |
S1 |
p. 140-
1 p.
|
artikel
|
| 54 |
One-year follow-up of quality of life in adults with untreated growth hormone deficiency
|
Badia, X.
|
|
1999
|
9 |
S1 |
p. 139-
1 p.
|
artikel
|
| 55 |
Perturbations of the hypothalamic-pituitary-adrenalaxis and the metabolic syndrome in ageing
|
Björntorp, P.
|
|
1999
|
9 |
S1 |
p. 121-123
3 p.
|
artikel
|
| 56 |
Reduced retinal vascularization in children with growth hormone deficiency
|
Hellström, A.
|
|
1999
|
9 |
S1 |
p. 163-
1 p.
|
artikel
|
| 57 |
Signal transduction of the growthhormone (GH) receptor, and GH-binding protein
|
Wojcik, J.
|
|
1999
|
9 |
S1 |
p. 51-55
5 p.
|
artikel
|
| 58 |
The effect of growth hormone (GH) replacementtherapy on endothelial function and oxidative stress in patients with hypopituitarism and GH deficiency
|
Evans, L.M.
|
|
1999
|
9 |
S1 |
p. 147-
1 p.
|
artikel
|
| 59 |
The effect of long-term growth hormone (GH)treatment on muscle GH-binding protein levels and GH receptor gene expression in humans
|
Khalfallah, Y.
|
|
1999
|
9 |
S1 |
p. 158-
1 p.
|
artikel
|
| 60 |
The effect of low-dose human growth hormonereplacement therapy on insulin action in patients with adult-onset hypopituitarism
|
McConnell, E.M.
|
|
1999
|
9 |
S1 |
p. 146-
1 p.
|
artikel
|
| 61 |
The effects of growth hormone (GH) replacement therapy on lipid metabolism and carbohydrate tolerance in adults with GH deficiency
|
Peñafiel, J.
|
|
1999
|
9 |
S1 |
p. 147-
1 p.
|
artikel
|
| 62 |
The effects of growth hormone therapy on overnight metabolic fuels in patients with hypopituitarism
|
Kousta, E.
|
|
1999
|
9 |
S1 |
p. 144-
1 p.
|
artikel
|
| 63 |
The effects of short-term growth hormone and insulin-like growth factor 1 treatment on thyroid hormone concentrations in adults with primary hypothyroidism
|
Jenkins, R.C.
|
|
1999
|
9 |
S1 |
p. 148-
1 p.
|
artikel
|
| 64 |
The growth hormone secretagogue hexarelinimproves cardiac function in rats following experimental myocardial infarction
|
Tivesten, Å.
|
|
1999
|
9 |
S1 |
p. 157-
1 p.
|
artikel
|
| 65 |
The growth hormone secretagogue receptor
|
Korbonits, M.
|
|
1999
|
9 |
S1 |
p. 93-99
7 p.
|
artikel
|
| 66 |
The insulin-like growth factor (IGF)-IGF-binding protein axis in critical illness
|
Baxter, R.C.
|
|
1999
|
9 |
S1 |
p. 67-69
3 p.
|
artikel
|
| 67 |
The mechanism of arginine- and insulin-induced growth hormone release in humans
|
Hanew, K.
|
|
1999
|
9 |
S1 |
p. 139-
1 p.
|
artikel
|
| 68 |
The role of growth hormone and insulin-like growth factor I in the regulation of apoptosis
|
Isgaard, J.
|
|
1999
|
9 |
S1 |
p. 125-128
4 p.
|
artikel
|
| 69 |
The severity of growth hormone deficiencyin adults is associated with impairment of bone status
|
Colao, A.
|
|
1999
|
9 |
S1 |
p. 160-
1 p.
|
artikel
|
| 70 |
The use of growth hormone (GH) secretagogues in the diagnosis of GH deficiency in humans
|
Peino, R.
|
|
1999
|
9 |
S1 |
p. 101-105
5 p.
|
artikel
|
| 71 |
Utilization of in-patient services and prevalenceof psychiatric illness in patients with hypopituitarism and growth hormone deficiency
|
Davies, J.S.
|
|
1999
|
9 |
S1 |
p. 140-141
2 p.
|
artikel
|
| 72 |
Validation of growth hormone provocation tests in young, healthy adults
|
Jocham, A.
|
|
1999
|
9 |
S1 |
p. 138-
1 p.
|
artikel
|
Tijdschrift beschrijving